|
|
Other links at Articles > Diabetes and Endocrinology |
| 2. |
First-Line EGFR Inhibition May Benefit Selected Lung Cancer Patients
|
|
|
There is "strong evidence" that selected groups of patients with advanced non-small cell lung cancer (NSCLC) may benefit from first-line therapy with an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, according to the authors of a report in the March issue of the Journal of Thoracic Oncology. Reuters Health Information
|
| 4. |
Case Manager Improves Treatment Rates in High-Risk Osteoporosis Patients
|
|
|
The use of a case manager can significantly improve the treatment rates of elderly osteoporosis patients who have sustained a hip fracture and are at high risk of future fractures, according to a report in the October 22nd issue of the Archives of Internal Medicine. Reuters Health Information
|
| 5. |
Autoantigen May Help Preserve Insulin Secretion in Type 1 Diabetes
|
|
|
Treatment with an alum formulation of glutamic acid decarboxylase (GAD-alum), a major autoantigen in patients with type 1 diabetes, preserves residual insulin secretion in young patients with recent-onset disease, investigators report, although it does not reduce insulin requirements. Reuters Health Information
|
|
|
